Home›People›David Callanan
DC

David Callanan

Executive officer at Aviceda Therapeutics.

Executive
Updated Oct 27, 2026·Latest SEC filing Jan 13, 2025·Suggest an edit

About David Callanan

David Callanan is an executive officer at Aviceda Therapeutics.

David Callanan first appears on SEC filings in 2024.

Experience

This experience comes from SEC filings. The years are when the filings name David Callanan in the role, so the role may have started earlier or lasted longer.

Aviceda Therapeutics, Inc.
Executive officer
2024 – 2025 · Cambridge, MA

Key Colleagues at Startups

The people David Callanan works with at each company, as listed on that company's latest Form D.

Aviceda Therapeutics, Inc. · Form D/A, Jan 13, 2025
NT
MG
Mohamed Genead
Executive officer and director
MT
Michael Tolentino
Executive officer and director
CA
TH
Tarek Hassan
Executive officer
EL
Erin Lavelle
Director
DG
David Guyer
Director
DK
Derek Kunimoto
Member of Office of CEO & President
JW
Jay Woods
Director

Sources

  1. SECAviceda Therapeutics, Inc. Form D/A, filed Jan 13, 2025